Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Biotec Pharmacon ASA

Closing information (x1000 SEK)

Closing information 2019/12 (consolidated) 2018/12 (consolidated) 2017/12 (consolidated)
Turnover 89,280 Less Arrow 74,599 Less Arrow 72,828
Financial expenses 858 Less Arrow 0 More Arrow 696
Earnings before taxes -6,269 Less Arrow -14,166 Less Arrow -24,827
Total assets 82,100 Less Arrow 69,680 Less Arrow 61,743
Current assets 61,981 Less Arrow 57,234 Less Arrow 50,015
Current liabilities 19,431 Less Arrow 14,463 More Arrow 16,886
Equity capital 49,166 More Arrow 55,217 Less Arrow 44,856
- share capital 51,133 Less Arrow 49,518 Less Arrow 43,987
Employees (average) 38 More Arrow 43 More Arrow 44
Shareholders 0 0 0

Financial ratios

Fiscal year 2019/12 (consolidated) 2018/12 (consolidated) 2017/12 (consolidated)
Solvency 59.9% More Arrow 79.2% Less Arrow 72.6%
Turnover per employee 2,349 Less Arrow 1,735 Less Arrow 1,655
Profit as a percentage of turnover -7.0% Less Arrow -19.0% Less Arrow -34.1%
Return on assets (ROA) -6.6% Less Arrow -20.3% Less Arrow -39.1%
Current ratio 319.0% More Arrow 395.7% Less Arrow 296.2%
Return on equity (ROE) -12.8% Less Arrow -25.7% Less Arrow -55.3%
Change turnover 12,248 Less Arrow 60 Less Arrow -5,854
Change turnover % 16% Less Arrow 0% Less Arrow -7%
Chg. No. of employees -5 More Arrow -1 Less Arrow -2
Chg. No. of employees % -12% More Arrow -2% Less Arrow -4%

Total value of public sale

Fiscal year 2019/12 (consolidated) 2018/12 (consolidated) 2017/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.